Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,008.00
Ask: 12,012.00
Change: 674.00 (5.94%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,096.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

22 May 2014 11:28

RNS Number : 8203H
GoldmanSachs International
22 May 2014
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ASTRAZENECA PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

ASTRAZENECA PLC

(d) Date dealing undertaken:

21 May 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES - disclosed previously for PFIZER INC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

USD 0.25 ordinary

Purchases

769,74711,780

44.5600 GBP487.3078 SEK

42.9940 GBP475.3000 SEK

USD 0.25 ordinary

Sales

1,729,39511,780

44.4800 GBP487.9000 SEK

43.2027 GBP481.7468 SEK

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

USD 0.25 ordinary

CFD

Reducing a long position

15,000

43.0495 GBP

USD 0.25 ordinary

CFD

Reducing a short position

13,560

43.7441 GBP

USD 0.25 ordinary

CFD

Reducing a short position

7,652

43.7441 GBP

USD 0.25 ordinary

CFD

Reducing a short position

28,788

43.7441 GBP

USD 0.25 ordinary

CFD

Reducing a short position

750

43.7723 GBP

USD 0.25 ordinary

CFD

Opening a long position

1,000

43.8762 GBP

USD 0.25 ordinary

CFD

Opening a long position

3,000

43.8867 GBP

USD 0.25 ordinary

CFD

Opening a short position

106

43.8980 GBP

USD 0.25 ordinary

CFD

Opening a short position

16

43.8980 GBP

USD 0.25 ordinary

CFD

Opening a short position

1,500

43.9846 GBP

USD 0.25 ordinary

CFD

Reducing a short position

1,500

44.0050 GBP

USD 0.25 ordinary

CFD

Reducing a short position

3,000

44.1534 GBP

USD 0.25 ordinary

CFD

Reducing a short position

2,800

44.1534 GBP

USD 0.25 ordinary

CFD

Reducing a short position

9,000

44.1620 GBP

USD 0.25 ordinary

CFD

Reducing a short position

21,000

44.1620 GBP

USD 0.25 ordinary

CFD

Reducing a short position

250

44.1850 GBP

USD 0.25 ordinary

CFD

Opening a long position

229

44.2000 GBP

USD 0.25 ordinary

CFD

Reducing a long position

2,000

44.2000 GBP

USD 0.25 ordinary

CFD

Opening a long position

32,746

44.2500 GBP

USD 0.25 ordinary

CFD

Reducing a long position

10,000

44.2768 GBP

USD 0.25 ordinary

CFD

Reducing a short position

15,000

72.2845 USD

USD 0.25 ordinary

SWAP

Reducing a short position

28,000

43.5478 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

7,000

43.5478 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

28,000

43.5478 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

7,000

43.5478 GBP

USD 0.25 ordinary

SWAP

Opening a long position

248,500

43.9000 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

56,000

43.9164 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

14,000

43.9164 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

18,400

43.9642 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

44,969

43.9642 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

11,242

43.9642 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

4,600

43.9642 GBP

USD 0.25 ordinary

SWAP

Reducing a long position

500,000

44.0150 GBP

USD 0.25 ordinary

SWAP

Opening a long position

106,270

44.0282 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

9,711

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

9,247

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

8,773

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

4,909

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

17,330

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

5,183

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

304

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

543

44.1867 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

4,250

44.2000 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,150

44.2000 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,267

44.2000 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

133

44.2000 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

6,347

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

11,891

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

6,013

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

927

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

8,795

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

8,319

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

14,986

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

373

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

16,478

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

15,781

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

515

44.2075 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

29,575

44.2075 GBP

USD 0.25 ordinary

SWAP

Opening a short position

1,300

44.2133 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

4,562

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,827

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

9,651

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,094

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

18,175

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

424

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

48,426

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

654

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

10,398

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

19,389

44.2563 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

31,758

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,376

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

5,154

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

9,164

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,698

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

222

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

21

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,439

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,555

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,363

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,291

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

19,136

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

81

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

292

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,363

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

375

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

25,038

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,580

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

5,350

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

79

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,500

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

96

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

2,122

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

699

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

5,860

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

84

44.3062 GBP

USD 0.25 ordinary

SWAP

Reducing a short position

1,304

44.3062 GBP

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

22 May 2014

Contact name:

Aadithya Rao and Yiannis Bardis

Telephone number:

+44(20) 7051 9046 / +44(20) 7774 7107

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBGGDULDDBGSD
Date   Source Headline
25th Apr 20247:00 amRNS1st Quarter Results
11th Apr 20245:30 pmRNSResult of AGM
11th Apr 20247:00 amRNSAstraZeneca increases 2024 dividend by 7%
8th Apr 20247:00 amRNSEnhertu approved in US for HER2+ solid tumours
5th Apr 20247:00 amRNSImfinzi improved OS & PFS in limited-stage SCLC
2nd Apr 20243:00 pmRNSTotal Voting Rights
2nd Apr 20247:05 amRNSVoydeya approved in US
2nd Apr 20247:00 amRNSFDA accepts Dato-DXd BLA for breast cancer
25th Mar 20247:00 amRNSUltomiris approved in the US for NMOSD
19th Mar 20247:00 amRNSAstraZeneca to acquire Fusion
14th Mar 20247:00 amRNSAstraZeneca to acquire Amolyt
12th Mar 202411:00 amRNSDirector/PDMR Shareholding
7th Mar 202411:00 amRNSNotice of AGM
6th Mar 20243:05 pmRNSDirector/PDMR Shareholding
6th Mar 20243:00 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSEMA validates Dato-DXd MAAs for NSQ NSCLC and BC
1st Mar 20243:00 pmRNSTotal Voting Rights
26th Feb 20247:00 amRNSVoydeya recommended for EU approval
22nd Feb 20241:15 pmRNSAcquisition of Gracell completed
22nd Feb 202411:00 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSAstraZeneca prices a $5bn bond offering
21st Feb 20247:00 amRNSFiling of Form 20-F with SEC
20th Feb 202411:00 amRNSAnnual Financial Report
19th Feb 20243:00 pmRNSAstraZeneca completes acquisition of Icosavax
19th Feb 20247:10 amRNSTagrisso plus chemo approved in US for lung cancer
19th Feb 20247:05 amRNSFDA accepts Dato-DXd BLA for nonsquamous NSCLC
19th Feb 20247:00 amRNSTagrisso improved PFS in Stage III lung cancer
8th Feb 20247:00 amRNSFinal Results
1st Feb 20243:00 pmRNSTotal Voting Rights
2nd Jan 20243:00 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSAstraZeneca acquires Gracell
22nd Dec 20237:00 amRNSWainua (eplontersen) granted first US FDA approval
14th Dec 20233:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:05 amRNSAstraZeneca to acquire Icosavax
1st Dec 20233:05 pmRNSBlock listing Interim Review
1st Dec 20233:00 pmRNSTotal Voting Rights
1st Dec 20237:00 amRNSDiscontinuation of two CRYSTALIZE evidence trials
23rd Nov 20233:00 pmRNSDirector/PDMR Shareholding
17th Nov 20237:00 amRNSTruqap approved in US for HR+ breast cancer
14th Nov 20237:05 amRNSUpdate on PACIFIC-2 Phase III trial for Imfinzi
9th Nov 20233:00 pmRNSDirector Declaration
9th Nov 20237:10 amRNSImfinzi combination improves PFS in liver cancer
9th Nov 20237:05 amRNSAgreement with Eccogene for clinical stage GLP-1RA
9th Nov 20237:00 amRNS9M and Q3 2023 results
1st Nov 20233:00 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSAstraZeneca cell & gene therapy deal w/ Cellectis
3rd Oct 20237:00 amRNSAstraZeneca settles Nexium liability litigations
2nd Oct 20233:00 pmRNSTotal Voting Rights
22nd Sep 20237:00 amRNSDato-DXd improved PFS in breast cancer
20th Sep 20237:00 amRNSAlexion completes Pfizer gene therapy agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.